美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
ADHANSIA XR	212038	001	NDA	METHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	25MG	Yes	No	2019/02/27	2019/02/27	PURDUE PHARMA LP	Discontinued
ADHANSIA XR	212038	002	NDA	METHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	35MG	Yes	No	2019/02/27	2019/02/27	PURDUE PHARMA LP	Discontinued
ADHANSIA XR	212038	003	NDA	METHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	45MG	Yes	No	2019/02/27	2019/02/27	PURDUE PHARMA LP	Discontinued
ADHANSIA XR	212038	004	NDA	METHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	55MG	Yes	No	2019/02/27	2019/02/27	PURDUE PHARMA LP	Discontinued
ADHANSIA XR	212038	005	NDA	METHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	70MG	Yes	No	2019/02/27	2019/02/27	PURDUE PHARMA LP	Discontinued
ADHANSIA XR	212038	006	NDA	METHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	85MG	Yes	No	2019/02/27	2019/02/27	PURDUE PHARMA LP	Discontinued